The highest dose of an experimental pill developed by Eli Lilly dramatically lowered an inherited form of high cholesterol in ...

Indianapolis-based Lilly is testing its weight loss drug Zepbound to treat addiction, while Meta outages affected more than 150,000 users, and insurance company stocks have fallen since the murder of ...

Ozempic and other GLP-1 drugs have surged in popularity, dominating U.S. medication spending in 2023 for their effectiveness in managing diabetes and promoting weight loss. As demand grows, promising ...

The pharmaceutical giant presented mid-stage trial data on the pill, muvalaplin ... so lifestyle changes such as diet or exercise have no effect, Ruth Gimeno, Lilly's group vice president for ...

CHICAGO (Reuters) - The highest dose of an experimental pill developed by Eli Lilly dramatically lowered ... bad cholesterol that can be treated with diet and statins, there are no approved ...